Literature DB >> 12787841

Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches.

Ingmar H A Franken1.   

Abstract

In the present review, an integrated approach to craving and addiction is discussed, which is based on recent insights from psychology and neuropsychopharmacology. An integrated model explains craving and relapse in humans by the psychological mechanism of "attentional bias" and provides neuropsychopharmacological mechanisms for this bias. According to this model, cognitive processes mediate between drug stimulus and the subject's response to this stimulus and subsequent behavioral response (e.g., drug use, relapse). According to the model, a conditioned drug stimulus produces an increase in dopamine levels in the corticostriatal circuit, in particular the anterior cingulate gyrus, amygdala, and nucleus accumbens, which in turn serves to draw the subject's attention towards a perceived drug stimulus. This process results in motor preparation and a hyperattentive state towards drug-related stimuli that, ultimately, promotes further craving and relapse. Evidence for this attentional bias hypothesis is reviewed from both the psychopharmacological and the neuroanatomical viewpoints. The attentional bias hypothesis raises several suggestions for clinical approaches and further research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787841     DOI: 10.1016/S0278-5846(03)00081-2

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  195 in total

1.  Neurofeedback Effects on Evoked and Induced EEG Gamma Band Reactivity to Drug-related Cues in Cocaine Addiction.

Authors:  Timothy Horrell; Ayman El-Baz; Joshua Baruth; Allan Tasman; Guela Sokhadze; Christopher Stewart; Estate Sokhadze
Journal:  J Neurother       Date:  2010-07

2.  Attentional biases for alcohol cues in heavy and light social drinkers: the roles of initial orienting and maintained attention.

Authors:  Matt Field; Karin Mogg; Jessica Zetteler; Brendan P Bradley
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

Review 3.  Prefrontal responses to drug cues: a neurocognitive analysis.

Authors:  Stephen J Wilson; Michael A Sayette; Julie A Fiez
Journal:  Nat Neurosci       Date:  2004-02-24       Impact factor: 24.884

4.  An early attentional bias to BEGIN-stimuli of the smoking ritual is accompanied with mesocorticolimbic deactivations in smokers.

Authors:  Bastian Stippekohl; Bertram Walter; Markus H Winkler; Ronald F Mucha; Paul Pauli; Dieter Vaitl; Rudolf Stark
Journal:  Psychopharmacology (Berl)       Date:  2012-04-03       Impact factor: 4.530

5.  Internet addiction: Neuroimaging findings.

Authors:  Kai Yuan; Wei Qin; Yijun Liu; Jie Tian
Journal:  Commun Integr Biol       Date:  2011-11-01

6.  Effect of craving induction on inhibitory control in opiate dependence.

Authors:  Antonio Verdejo-García; Dan I Lubman; Anne Schwerk; Kim Roffel; Raquel Vilar-López; Trudi Mackenzie; Murat Yücel
Journal:  Psychopharmacology (Berl)       Date:  2011-09-28       Impact factor: 4.530

Review 7.  Attentional bias in problem gambling: a systematic review.

Authors:  Audhild Hønsi; Rune Aune Mentzoni; Helge Molde; Ståle Pallesen
Journal:  J Gambl Stud       Date:  2013-09

Review 8.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

9.  Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward.

Authors:  Tom P Freeman; Ravi K Das; Sunjeev K Kamboj; H Valerie Curran
Journal:  Soc Cogn Affect Neurosci       Date:  2014-02-12       Impact factor: 3.436

10.  The relationship between impulsivity and craving in alcohol dependent patients.

Authors:  L Joos; A E Goudriaan; L Schmaal; N A J De Witte; W Van den Brink; B G C Sabbe; G Dom
Journal:  Psychopharmacology (Berl)       Date:  2012-10-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.